Astellas aims to create innovative pharmaceuticals for diseases with high unmet medical needs through our Focus Area approach.

Using the Focus Area approach, we prioritise our research and development strategy utilising three perspectives:

  1. Biology - clear mechanisms of pharmacological action with accompanying scientific progress
  2. Modality - the best delivery method to maximise pharmacological effects
  3. Disease - widespread evaluation of unmet medical needs and the market environment.

Where there is clear scientific evidence and the potential to deliver VALUE to patients, we optimise resource allocation for priority candidates to accelerate progress from the early development stages.


MAT-GB-NON-2024-00074 April 2024